Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
In the absence of other risk factors, do you treat the regional lymph nodes in triple negative breast cancer?
Or for that matter, offer PMRT on the basis of a patient having triple negative disease?
Answer from: Radiation Oncologist at Community Practice
At present I don't, but once Canadian and EORTC studies are published with full details available, it may change practice patterns.
Sign in or Register to read more
415
Related Questions
What are the advantages/disadvantages of using static IMRT vs VMAT when treating breast cancer?
How would you manage a patient presenting with recurrent cT4 breast cancer?
Is there a role for radiation therapy for florid LCIS managed with lumpectomy?
Would you offer a patient with “good-risk” DCIS and an elevated DCISionRT score APBI or WBI?
What is the current paradigm for breast cancer diagnosed with isolated metastases prior to initial treatment?
How would you treat a young breast cancer patient with limited nodal involvement and an isolated sternal oligometastasis at diagnosis?
Would you consider omitting PMRT in cT3N0 triple negative breast cancer with a pCR?
In the post-mastectomy setting, are there situations where only the regional nodes or targeted nodal basis are covered?
Do you recommend re-excision of a unifocal positive anterior margin at skin after lumpectomy in a patient with otherwise low risk breast cancer features?
Would you start any treatment for radiation pneumonitis if there is a large area of consolidation in the irradiated lung field but the patient is asymptomatic?